Narcolepsy Global Market Report 2024

Description

Narcolepsy drugs are medications specifically formulated to manage and alleviate the symptoms of narcolepsy, a chronic neurological disorder characterized by excessive daytime sleepiness (EDS), sudden episodes of muscle weakness or paralysis (cataplexy), sleep paralysis, and hallucinations. These medications are often used in combination and customized to meet the individual needs of patients, aiming to enhance their quality of life by reducing the severity of narcolepsy symptoms.

The main types of narcolepsy drugs address narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy. Narcolepsy with Cataplexy involves sudden, temporary muscle weakness or paralysis triggered by intense emotions such as laughter, surprise, or anger. Various medications are used to treat symptoms such as excessive daytime sleepiness, cataplexy, and other related conditions. These therapeutics include sodium oxybate, central nervous system stimulants, tricyclic antidepressants, selective serotonin reuptake inhibitors, and other treatments.

The narcolepsy drugs market research report is one of a series of new reports from The Business Research Company that provides narcolepsy drugs market statistics, including narcolepsy drugs industry global market size, regional shares, competitors with a narcolepsy drugs market share, detailed narcolepsy drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the narcolepsy drugs industry. This narcolepsy drugs research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The narcolepsy drugs market size has grown strongly in recent years. It will grow from $3.31 billion in 2023 to $3.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased awareness and diagnosis of narcolepsy, improved treatment options becoming available, regulatory approvals for new therapies, rising rates of awareness and diagnosis among healthcare providers and the public, and the expansion of healthcare services aimed at managing neurological disorders.

The narcolepsy drugs market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to several factors including the rising prevalence of sleep disorders, advances in personalized medicine, an aging population more susceptible to sleep disorders, increasing support and assistance programs for patients, and expanding healthcare coverage. Major trends anticipated during this period include technological innovations, pharmaceutical companies adopting more patient-centric approaches, ongoing research and development in biologic therapies, the development of innovative drug formulations, and a growing preference for non-stimulant alternatives in treatment.

The narcolepsy drugs market is expected to experience growth driven by increasing demand for personalized medicine. Personalized medicine involves tailoring treatments to meet individual patient needs, leveraging advancements in omics technology, data integration, genetics, and a deeper understanding of personalized therapies and preventative measures. Narcolepsy drugs play a crucial role in personalized medicine by customizing treatment plans based on factors such as genetic profiles, symptom severity, metabolic rates, and patient preferences, aiming to maximize efficacy while minimizing side effects. For example, the Personalized Medicine Coalition reported a notable increase in approvals of customized medications in 2022, accounting for 34% of newly approved treatments, highlighting the growing preference for personalized approaches. Thus, the rising demand for personalized medicine is a key driver of growth in the narcolepsy drugs market.

Leading companies in the narcolepsy drugs market are innovating with products such as extended-release therapeutics to improve treatment outcomes and patient satisfaction. Extended-release (ER) formulations offer benefits such as improved medication adherence, stable drug levels, reduced side effects, and enhanced symptom management for narcolepsy patients. For instance, Avadel Pharmaceuticals recently introduced Lumryz, an extended-release sodium oxybate medication approved by the US FDA. Lumryz features an innovative mechanism that maintains consistent therapeutic levels overnight with a single dose, offering convenience and potentially improving patient compliance compared to traditional dosing schedules. This advancement addresses a significant need in narcolepsy treatment, aiming to simplify therapy and enhance overall quality of life for patients.

In May 2022, Axsome Therapeutics Inc., a US biopharmaceutical company, acquired Sunosi from Jazz Pharmaceuticals for $53 million. This acquisition expands Axsome's portfolio in the central nervous system (CNS) area by incorporating Sunosi, a medication designed to promote wakefulness in adults with excessive daytime sleepiness linked to narcolepsy or obstructive sleep apnea. Jazz Pharmaceuticals, based in Ireland, is a prominent player in the narcolepsy drugs market.

Major companies operating in the narcolepsy drugs market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceutical plc, Ipsen Group, Lundbeck AS, Hikma Pharmaceuticals plc, Lupin Limited, Viatris Inc., Harmony Biosciences Holdings Inc., Ligand Pharmaceuticals Incorporated, Sumitomo Dainippon Pharma Co. Ltd., Avadel Pharmaceuticals plc, Bioprojet Pharma s.a.r.l, Graymark Healthcare Inc., Flamel Technologies SA, Arena Pharmaceuticals

North America was the largest region in the narcolepsy drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the narcolepsy drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The narcolepsy drugs market consists of sales of orexin receptor antagonists, stimulants, and orexin-based therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Narcolepsy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on narcolepsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for narcolepsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The narcolepsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Type 1; Type 2
2) By Treatment: Antidepressants; Stimulants; Sodium Oxybate; Other Treatments
3) By Diagnosis: Poysomnogram; Multiple Sleep Latency Test
4) By End Users: Hospitals; Retail Pharmacies; Other End Users
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; Novartis AG; Takeda Pharmaceutical Company Limited; Viatris Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18934

1. Executive Summary

2. Narcolepsy Market Characteristics

3. Narcolepsy Market Trends And Strategies

4. Narcolepsy Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Narcolepsy Market Size and Growth

5.1. Global Narcolepsy Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Narcolepsy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Narcolepsy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Narcolepsy Market Segmentation

6.1. Global Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Type 1
Type 2
6.2. Global Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antidepressants
Stimulants
Sodium Oxybate
Other Treatments
6.3. Global Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Poysomnogram
Multiple Sleep Latency Test
6.4. Global Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Retail Pharmacies
Other End Users

7. Narcolepsy Market Regional And Country Analysis

7.1. Global Narcolepsy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Narcolepsy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Narcolepsy Market

8.1. Asia-Pacific Narcolepsy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Narcolepsy Market

9.1. China Narcolepsy Market Overview
9.2. China Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Narcolepsy Market

10.1. India Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Narcolepsy Market

11.1. Japan Narcolepsy Market Overview
11.2. Japan Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Narcolepsy Market

12.1. Australia Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Narcolepsy Market

13.1. Indonesia Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Narcolepsy Market

14.1. South Korea Narcolepsy Market Overview
14.2. South Korea Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Narcolepsy Market

15.1. Western Europe Narcolepsy Market Overview
15.2. Western Europe Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Narcolepsy Market

16.1. UK Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Narcolepsy Market

17.1. Germany Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Narcolepsy Market

18.1. France Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Narcolepsy Market

19.1. Italy Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Narcolepsy Market

20.1. Spain Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Narcolepsy Market

21.1. Eastern Europe Narcolepsy Market Overview
21.2. Eastern Europe Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Narcolepsy Market

22.1. Russia Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Narcolepsy Market

23.1. North America Narcolepsy Market Overview
23.2. North America Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Narcolepsy Market

24.1. USA Narcolepsy Market Overview
24.2. USA Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Narcolepsy Market

25.1. Canada Narcolepsy Market Overview
25.2. Canada Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Narcolepsy Market

26.1. South America Narcolepsy Market Overview
26.2. South America Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Narcolepsy Market

27.1. Brazil Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Narcolepsy Market

28.1. Middle East Narcolepsy Market Overview
28.2. Middle East Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Narcolepsy Market

29.1. Africa Narcolepsy Market Overview
29.2. Africa Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Narcolepsy Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Narcolepsy Market Competitive Landscape And Company Profiles

30.1. Narcolepsy Market Competitive Landscape
30.2. Narcolepsy Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Takeda Pharmaceutical Company Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Viatris Inc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Narcolepsy Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries
31.2. Otsuka Pharmaceutical
31.3. Sumitomo Pharma Company Limited
31.4. Jazz Pharmaceuticals
31.5. Ono Pharmaceutical Co. Ltd
31.6. Lupin Pharmaceuticals
31.7. Alkermes
31.8. Harmony Biosciences
31.9. Arena Pharmaceuticals
31.10. Cerevel Therapeutics
31.11. Axsome Therapeutics Inc.
31.12. Avadel Pharmaceuticals
31.13. NLS Pharmaceutics AG
31.14. KemPharm
31.15. Suven Life Sciences Ltd

32. Global Narcolepsy Market Competitive Benchmarking

33. Global Narcolepsy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Narcolepsy Market

35. Narcolepsy Market Future Outlook and Potential Analysis

35.1 Narcolepsy Market In 2028 - Countries Offering Most New Opportunities
35.2 Narcolepsy Market In 2028 - Segments Offering Most New Opportunities
35.3 Narcolepsy Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer